Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 36 for “"Cardiorenal"”.
-
Haemodynamic Interactions in Cardiorenal Syndrome
Cardiorenal syndrome (CRS) is associated with increased morbidity and mortality across the heart failure spectrum. This thesis identifies and addresses key gaps in the definition of the clinical syndrome, investigates biomarkers and clinical parameters predicting CRS, and finally explores the …
-
¿CARDIORENAL SYNDROME-ANEMIA¿ COMPLEX IN SMALL ANIMAL MEDICINE: RESEARCH IN DIAGNOSTIC
La sindrome cardiorenale (CRS) può essere definita come un disordine fisiopatologico di cuore e reni in cui la disfunzione acuta o cronica di un organo può indurre una disfunzione acuta o cronica dell'altro. La cardiopatia acquisita più comune che colpisce i cani anziani e che porta a …
-
Socioeconomic Status, HBB, and TTR Variants, and Cardiorenal Outcomes: The Regards Study
… and HBB genetic variants and their respective cardiorenal outcomes. To test the association between the genetic risk variants and the incident outcomes we used a multivariable Cox proportional hazards regression. We identified and adjusted for potential confounders and while there was …
-
The cardiorenal syndrome: Structural and functional aspects including associations with the shrunken pore syndrome
… between the two organs is referred to as cardiorenal syndrome (CRS). Mortality and morbidity rates are increased in patients with CRS, and early detection of this syndrome can lead to a reduction in the disease burden. To more accurately stage CKD and calculate the mortality risk, the eGFR …
-
Deciphering The Effects Of Serelaxin On The Cardiorenal Axis In Acute Heart Failure- A Canine Model
Acute heart failure (HF) with underlying ischemic cardiomyopathy (ICM) is one of the leading causes of cardiovascular associated death in the United States. Acute HF pathophysiology involves a complex interplay of neurohormonal activation, increased cardiac ventricular pressures (fluid overload), …
-
Quality use of sodium-glucose cotransporter 2 inhibitors – expanding the treatment focus from glycaemic control to cardiorenal protection
… medicines, SGLT2i were discovered to have key cardiorenal benefits for people with type 2 diabetes. Incredibly, during the period of my PhD candidature, SGLT2i have become a pillar of therapy for heart failure (HF) and chronic kidney disease (CKD), irrespective of the presence of diabetes. A …
-
Metabolic and cardiorenal outcomes of heart transplantation, and the role of peri-transplant sodium glucose co-transporter 2 inhibitors
… improve HTx outcomes, addressing metabolic and cardiorenal complications. However, research of SGLT2 inhibitors in HTx recipients has been limited to small retrospective cohort studies with inherent limitations related to study design. Potential concerns related to SGLT2 inhibitor use in HTx …
-
Multidimensional early postnatal stress permanently programs metabolism, development, and behaviour: linking trauma to adverse health outcomes
… proton nuclear magnetic spectroscopy to analyze cardiorenal and cerebral metabolomes of animals exposed to a multidimensional early-life stressor, and (ii) used immunohistochemical, transcriptomic, and behavioural analyses to examine the impacts of multidimensional early-life stress on offspring …
-
Θεραπείες νεφρικής υποκατάστασης σε ασθενείς με τελικού σταδίου καρδιακή ανεπάρκεια και καρδιονεφρικό σύνδρομο
… of decongestion in heart failure patients with cardiorenal syndrome and refractory congestion despite diuretic therapy. Although there are a lot of trials concerning ultrafiltration therapy in acute heart failure decompensation, most of them with positive results, the bibliographic data of …
-
Implication de la dipeptidyl peptidase IV dans l’insuffisance cardiaque expérimentale et clinique
… tachycardiomyopathy, inhibition of DPP4 reduces cardiorenal dysfunction increases the effectiveness of exogenous BNP1-32 and decreases myocardial molecular alterations. In the first study, we identified physiologic determinants of plasma DPP4 activity and evaluated DPP4 activity in dogs in heart …
-
Disparities And Barriers In The Utilization Of Glucose-Lowering Therapies For Type 2 Diabetes
… and is associated with increased risk of cardiorenal complications that might be prevented with treatment. Newer glucose‑lowering therapies, glucagon‑like peptide‑1 receptor agonists (GLP‑1 RA) and sodium–glucose cotransporter‑2 inhibitors (SGLT2i), provide significant glycemic and …
-
From measurement to management of kidney function: population-based insights into biomarker discordance, risk factors, and outcomes
… treatment strategies and their potential cardiorenal benefits. A total of five published manuscripts were included in this thesis to achieve the above aims. These studies utilized data from the UK Biobank and several Swedish national registers. The first study in Chapter 4 presents a …
-
Insights on safety and efficacy of sodium-glucose cotransporter-2 inhibitors : perspectives on cardiovascular, renal, and cancer outcomes
… UACR risk groups and composite heart failure and cardiorenal outcomes which included cardiovascular death. For other cardiovascular and renal outcomes, no interaction was observed between KDIGO and UACR risk groups, although larger absolute risk reductions were observed in groups with a greater …
-
Obstructive sleep apnea treatment with continuous positive airway pressure therapy improves renin angiotensin system activity
… sleep apnea (OSA) is strongly associated with cardiorenal disease. Limited studies suggest that renin angiotensin system (RAS) activation may mediate this relationship. We sought to determine the effect of continuous positive airway pressure (CPAP) on the hemodynamic and circulating RAS …
-
Μελέτη της επίδρασης της χημειοθεραπείας που περιλαμβάνει ανθρακυκλίνες στην καρδιακή λειτουργεία ασθενών με κακοήθη λεμφώματα
… 37 males (52.9%) aged 44±19 years free from any cardiorenal and metabolic comorbidity. 45 (64.2%) had a non-Hodgkin lymphoma and the remaining a Hodgkin lymphoma. All participants were evaluated with echocardiography, laboratory and clinical examinations to estimate cardiac function and aortic …
-
Caracterización de los pacientes con síndrome cardiorrenal tipo I y II en diálisis peritoneal en un centro de diálisis en Bogotá
… and mortality in patients with type I and II cardiorenal syndrome in peritoneal dialysis at a Bogotá dialysis center between 2013 and 2016. Methodology: A retrospective cohort study was performed. Adult patients with SCR I and II who entered the center for PD from 08/08/2013 to 08/18/16 were …
-
Molekulare Mechanismen mit Einfluss auf kardiorenale Endorganschäden bei arterieller Hypertonie
… mechanisms involved in the development of cardiorenal organ damage in hypertension. Left ventricular hypertrophy is one of the main risk factors for adverse cardiovascular events and mortality. Recently, a novel candidate gene encoding the carboxypeptidase X member 2 (CPXM2) was found to be …
-
The Role of Renal Nerves in the Development and Maintenance of a Model of Autosomal Recessive Polycystic Kidney Disease
… the pathogenesis of hypertension (HTN) and other cardiorenal conditions, but little work has been done to investigate whether they play a role in the pathogenesis of PKD. Furthermore, arginine vasopressin (AVP) is elevated in PKD and increases cyst growth. There is evidence that activation of the …
-
Renal and vascular mechanisms of salt-induced hypertension in C57BL6/J mice
… the higher the incidence of hypertension and its cardiorenal consequences within a population. However, the underlying mechanisms responsible remain controversial. Research supports roles for both the kidneys and the vasculature in salt-induced hypertension. Here, I investigated the effect of a …
Page 1 of 2